TCROSS News
journal Conference Topics Feature

List of Conference Articles

Comparison of the Prognosis between Drug-eluting Stents and Drug-coated Balloon in Small Vessel Coronary Lesions in Hemodialysis Patients
89th Japan Circulator Society Academic Conference|
Comparison of the Prognosis between Drug-eluting Stents and Drug-coated Balloon in Small Vessel Coronary Lesions in Hemodialysis Patients
Optimal Imaging Modality for Predicting Wall Motion Recovery after PCI in Chronic Total Occlusion
89th Japan Circulator Society Academic Conference|
Optimal Imaging Modality for Predicting Wall Motion Recovery after PCI in Chronic Total Occlusion
Clopidogrel versus Aspirin Monotherapy in Patients with High Ischemic Risk after PCI: SMART-CHOICE 3 Trial
ACC.25|
Clopidogrel versus Aspirin Monotherapy in Patients with High Ischemic Risk after PCI: SMART-CHOICE 3 Trial
Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial
ACC.25|
Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial
REHEALTH AF Study: Evaluating Healthy Life Expectancy and Long-Term Outcomes After Catheter Ablation in the Very Elderly
89th Japan Circulator Society Academic Conference|
REHEALTH AF Study: Evaluating Healthy Life Expectancy and Long-Term Outcomes After Catheter Ablation in the Very Elderly
Characteristics of AMI Attributable to Idiopathic Spontaneous Coronary Artery Dissection: Clinical Evidence from the Nationwide JROAD-DPC Database
89th Japan Circulator Society Academic Conference|
Characteristics of AMI Attributable to Idiopathic Spontaneous Coronary Artery Dissection: Clinical Evidence from the Nationwide JROAD-DPC Database
Comparison of angiography-derived fractional flow reserve-guided and intravascular ultrasound-guided PCI strategies: The FLAVOUR II Trial
ACC.25|
Comparison of angiography-derived fractional flow reserve-guided and intravascular ultrasound-guided PCI strategies: The FLAVOUR II Trial
Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial
ACC.25|
Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial
Impact of Guideline-Directed Medical Therapy on 2-Year Mortality in Japanese Patients Undergoing Endovascular Therapy for Femoropopliteal Lesions: LEADers-FP Registry
89th Japan Circulator Society Academic Conference|
Impact of Guideline-Directed Medical Therapy on 2-Year Mortality in Japanese Patients Undergoing Endovascular Therapy for Femoropopliteal Lesions: LEADers-FP Registry
The Efficacy and Safety of Mavacamten in Japanese Patients with Obstructive Hypertrophic Cardiomyopathy: Week 54 results from the HORIZON-HCM Study
89th Japan Circulator Society Academic Conference|
The Efficacy and Safety of Mavacamten in Japanese Patients with Obstructive Hypertrophic Cardiomyopathy: Week 54 results from the HORIZON-HCM Study
Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: The ONCO PE Trial
AHA 2024|
Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: The ONCO PE Trial
Efficacy and Safety of Edoxaban in Anticoagulant Therapy after Surgical Bioprosthetic Valve Replacement: The ENBALV Trial
AHA 2024|
Efficacy and Safety of Edoxaban in Anticoagulant Therapy after Surgical Bioprosthetic Valve Replacement: The ENBALV Trial
Percutaneous Transmural Arterial Bypass for Treatment of Femoropopliteal Disease: 3 Year Results of the DETOUR-2 Study
VIVA 2024|
Percutaneous Transmural Arterial Bypass for Treatment of Femoropopliteal Disease: 3 Year Results of the DETOUR-2 Study
Laser and Optics-Based Peripheral Intravascular Lithotripsy System for the Treatment of Above-the-Knee and Below-the-Knee Calcified Lesions: The RESTORE ATK and RESTORE BTK Trials
VIVA 2024|
Laser and Optics-Based Peripheral Intravascular Lithotripsy System for the Treatment of Above-the-Knee and Below-the-Knee Calcified Lesions: The RESTORE ATK and RESTORE BTK Trials
Mini S/FORWARD PAD IDE Study
VIVA 2024|
Mini S/FORWARD PAD IDE Study
Directional atherectomy versus balloon angioplasty before DCB for long calcified lesions of the femoral popliteal artery: The Total REALITY study
VIVA 2024|
Directional atherectomy versus balloon angioplasty before DCB for long calcified lesions of the femoral popliteal artery: The Total REALITY study
The Shockwave Intravascular Lithotripsy System for Treatment of Calcified Below-the-Knee Peripheral Arterial Disease: Thirty-Day Outcomes From the Disrupt PAD BTK Ⅱ Study
VIVA 2024|
The Shockwave Intravascular Lithotripsy System for Treatment of Calcified Below-the-Knee Peripheral Arterial Disease: Thirty-Day Outcomes From the Disrupt PAD BTK Ⅱ Study
Comparison of Puncture Success Rate between Distal Radial Access and Trans Radial Access in Patients with ST-elevation Myocardial Infarction: The DRAMI Trial
TCT 2024|
Comparison of Puncture Success Rate between Distal Radial Access and Trans Radial Access in Patients with ST-elevation Myocardial Infarction: The DRAMI Trial
Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: The HELP-PCI Trial
TCT 2024|
Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: The HELP-PCI Trial
Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery: The SIRONA Randomized Controlled Trial
TCT 2024|
Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery: The SIRONA Randomized Controlled Trial
QFR vs FFR-guided PCI: The FAVOR III Europe Trial
TCT 2024|
QFR vs FFR-guided PCI: The FAVOR III Europe Trial
A Large-scale, Randomized Trial of Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation: The ECLIPSE Trial
TCT 2024|
A Large-scale, Randomized Trial of Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation: The ECLIPSE Trial
Drug-coated Balloon Angioplasty for Side Branch During Provisional Stenting: The DCB-BIF Trial
TCT 2024|
Drug-coated Balloon Angioplasty for Side Branch During Provisional Stenting: The DCB-BIF Trial
Complete vs. Culprit-Only Revascularization in Older STEMI Patients: The EARTH-STEMI meta-analysis
ESC 2024|
Complete vs. Culprit-Only Revascularization in Older STEMI Patients: The EARTH-STEMI meta-analysis
Long-Term Outcomes with PCI Guided by Fractional Flow Reserve: 10 Years Follow-up of the FAME 2 Trial
ESC 2024|
Long-Term Outcomes with PCI Guided by Fractional Flow Reserve: 10 Years Follow-up of the FAME 2 Trial
Optical Coherence Tomography-guided Coronary Intervention in Patients with Complex Lesions: The OCCUPI Randomized Clinical Trial
ESC 2024|
Optical Coherence Tomography-guided Coronary Intervention in Patients with Complex Lesions: The OCCUPI Randomized Clinical Trial
Continuation versus Interruption of Oral Anticoagulation during TAVI: The POPular PAUSE TAVI Trial
ESC 2024|
Continuation versus Interruption of Oral Anticoagulation during TAVI: The POPular PAUSE TAVI Trial
Clopidogrel versus Aspirin Monotherapy Beyond 1 Month after PCI with DES: Final 1-year Results from the STOPDAPT-3 Trial
ESC|
Clopidogrel versus Aspirin Monotherapy Beyond 1 Month after PCI with DES: Final 1-year Results from the STOPDAPT-3 Trial
PCI in patients undergoing transcatheter aortic valve implantation: The NOTION-3 Trial
ESC|
PCI in patients undergoing transcatheter aortic valve implantation: The NOTION-3 Trial
Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients with DES Undergoing Low-to-intermediate Risk Non-cardiac Surgery: The ASSURE DES Randomized Clinical Trial
ESC|
Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients with DES Undergoing Low-to-intermediate Risk Non-cardiac Surgery: The ASSURE DES Randomized Clinical Trial